Managing Primary Biliary Cholangitis Progression and Symptoms — Though only one approved agent has been available for decades, the armamentarium has expanded ...

Primary biliary cholangitis (PBC) can deliver a significant blow to patients' quality of life, especially if they are not appropriately diagnosed and treated.

The table below is a review of notable updates that occurred in June 2025 for investigational products in development (not an inclusive list). Click on ...

FDA approves Ipsen's Iqirvo for primary biliary cholangitis, ending a 10-year hiatus in new therapies for the rare cholestatic liver disease.

Primary sclerosing cholangitis (PSC) affects the liver and bile ducts. Symptoms and treatment vary from person to person. PSC is a rare liver disease that affects the bile ducts.

FDA approves Gilead's Livdelzi for primary biliary cholangitis, setting up a contest with Ipsen's recent launch Iqirvo in the second-line setting.

Once clinical suspicion has been established for primary biliary cholangitis (PBC), the "serologic hallmark" of the autoimmune disease are anti-mitochondrial antibodies (AMA), present in ...

Primary biliary cholangitis is a chronic autoimmune disease critically linked to immunological dysregulation but the local immune-pathogenesis is poorly understood. Here the authors present single ...

A new study has revealed that about 5% of U.S. adults have taken supplements, such as turmeric, green tea, and ashwagandha, that have the potential to harm the liver.

Neurofibromatosis Type 1 (NF1) is a genetic disorder characterised by benign tumours and cutaneous lesions, including neurofibromas. This case report describes a boy in his early 10s with NF1 who ...

The gallbladder is located underneath the liver. If you’re not sure what’s flaring, read on to learn how to differentiate gallbladder and liver pain.